Torthaí cuardaigh - SATO, YASUYOSHI
- 1 - 15 toradh as 15 á dtaispeáint
-
1
Changes in Treatment Behavior during the COVID-19 Pandemic among Patients at a Cancer Hospital de réir Sato, Yasuyoshi, Fujiwara, Yu, Fukuda, Naoki, Hayama, Brian, Ito, Yoshinori, Ohno, Shinji, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
2
Two distinct phenotypes of immunologically hot gastric cancer subtypes de réir Saito, Noriyuki, Kobayashi, Yukari, Nagaoka, Koji, Kushihara, Yoshihiro, Sato, Yasuyoshi, Wada, Ikuo, Kakimi, Kazuhiro, Seto, Yasuyuki
Foilsithe / Cruthaithe 2021Téacs -
3
Selection of RNA-based evaluation methods for tumor microenvironment by comparing with histochemical and flow cytometric analyses in gastric cancer de réir Saito, Noriyuki, Sato, Yasuyoshi, Abe, Hiroyuki, Wada, Ikuo, Kobayashi, Yukari, Nagaoka, Koji, Kushihara, Yoshihiro, Ushiku, Tetsuo, Seto, Yasuyuki, Kakimi, Kazuhiro
Foilsithe / Cruthaithe 2022Téacs -
4
Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib de réir FUKUDA, NAOKI, WANG, XIAOFEI, OHMOTO, AKIHIRO, URASAKI, TETSUYA, SATO, YASUYOSHI, NAKANO, KENJI, NISHIZAWA, MASATOSHI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2020Téacs -
5
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer de réir SATO, YASUYOSHI, FUKUDA, NAOKI, FUJIWARA, YU, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, NAKANO, KENJI, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2021Téacs -
6
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial de réir Sato, Yasuyoshi, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Ohmoto, Akihiro, Nakano, Kenji, Yunokawa, Mayu, Ono, Makiko, Sato, Yukiko, Mitani, Hiroki, Tomomatsu, Junichi, Takahashi, Shunji
Foilsithe / Cruthaithe 2020Téacs -
7
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients de réir Fukuda, Naoki, Yunokawa, Mayu, Fujiwara, Yu, Wang, Xiaofei, Ohmoto, Akihiro, Hayashi, Naomi, Urasaki, Tetsuya, Sato, Yasuyoshi, Nakano, Kenji, Ono, Makiko, Tomomatsu, Junichi, Mitani, Hiroki, Takahashi, Shunji
Foilsithe / Cruthaithe 2020Téacs -
8
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib de réir FUKUDA, NAOKI, TODA, KAZUHISA, FUJIWARA, YU, WANG, XIAOFEI, OHMOTO, AKIHIRO, URASAKI, TETSUYA, HAYASHI, NAOMI, SATO, YASUYOSHI, NAKANO, KENJI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2020Téacs -
9
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy de réir Hayashi, Naomi, Sato, Yasuyoshi, Fujiwara, Yu, Fukuda, Naoki, Wang, Xiaofei, Nakano, Kenji, Urasaki, Testuya, Ohmoto, Akihiro, Ono, Makiko, Tomomatsu, Junichi, Sato, Yukiko, Mitani, Hiroki, Toshiyasu, Takashi, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
10
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line de réir Nakano, Kenji, Hayakawa, Keiko, Funauchi, Yuki, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Tomomatsu, Junichi, Ono, Makiko, Taira, Shinichiro, Nishizawa, Masatoshi, Wang, Xiaofei, Ohmoto, Akihiro, Sato, Yasuyoshi, Fukuda, Naoki, Urasaki, Tetsuya, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
11
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma de réir Ohmoto, Akihiro, Sato, Yukiko, Asaka, Reimi, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Hayashi, Naomi, Sato, Yasuyoshi, Nakano, Kenji, Yunokawa, Mayu, Ono, Makiko, Tomomatsu, Junichi, Toshiyasu, Takashi, Mitani, Hiroki, Takeuchi, Kengo, Mori, Seiichi, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
12
Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue Sarcoma de réir SATO, YASUYOSHI, NAKANO, KENJI, KAWAGUCHI, KUNIKI, FUKUDA, NAOKI, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, HAYASHI, NAOMI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, HAYAKAWA, KEIKO, FUNAUCHI, YUKI, TANIZAWA, TAISUKE, AE, KEISUKE, MATSUMOTO, SEIICHI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2021Téacs -
13
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma de réir Sato, Yasuyoshi, Nakano, Kenji, Wang, Xiaofei, Fukuda, Naoki, Urasaki, Tetsuya, Ohmoto, Akihiro, Hayashi, Naomi, Yunokawa, Mayu, Ono, Makiko, Tomomatsu, Junichi, Saito, Masanori, Minami, Yusuke, Hayakawa, Keiko, Funauchi, Yuki, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
14
Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor‐infiltrating cells de réir Sato, Yasuyoshi, Wada, Ikuo, Odaira, Kosuke, Hosoi, Akihiro, Kobayashi, Yukari, Nagaoka, Koji, Karasaki, Takahiro, Matsushita, Hirokazu, Yagi, Koichi, Yamashita, Hiroharu, Fujita, Masashi, Watanabe, Shuichi, Kamatani, Takashi, Miya, Fuyuki, Mineno, Junichi, Nakagawa, Hidewaki, Tsunoda, Tatsuhiko, Takahashi, Shunji, Seto, Yasuyuki, Kakimi, Kazuhiro
Foilsithe / Cruthaithe 2020Téacs -
15
Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital de réir Fujiwara, Yu, Sato, Yasuyoshi, Wang, Xiaofei, Oikado, Katsunori, Sato, Yoshinao, Fukuda, Naoki, Enokida, Taisuke, Takeda, Koichi, Ohkushi, Daisuke, Hayama, Brian, Egi, Yoko, Tokai, Yoshitaka, Yamada, Yumi, Nakajima, Yuki, Kubota, Motoko, Haruki, Satomi, Shimizu, Takako, Uchida, Yasuko, Utsugi, Kuniko, Ito, Yoshinori, Ohno, Shinji, Takahashi, Shunji, Tsuchida, Tomohiro
Foilsithe / Cruthaithe 2020Téacs